Virus and host genes and the outcome of infection. Viruses cause infection of all animals including people and the outcome of infection is highly variable. This project aims to use genetics to explain why some animals are more susceptible to particular virus infections and some strains of virus cause more severe diseases. The project will also explore whether all cells are similarly susceptible to killing by viruses.
The effect of age on regulatory T cell control of the innate and adaptive antiviral immune responses. Viral pathogens are a lead cause of infant mortality in the world. This project will define how T regulatory cells limit protective antiviral immune responses in the young. This information is critical for the development of potent antiviral vaccines that are effective from the newborn period without inducing autoimmunity. It will also provide novel insight into the way T regulatory cells can b ....The effect of age on regulatory T cell control of the innate and adaptive antiviral immune responses. Viral pathogens are a lead cause of infant mortality in the world. This project will define how T regulatory cells limit protective antiviral immune responses in the young. This information is critical for the development of potent antiviral vaccines that are effective from the newborn period without inducing autoimmunity. It will also provide novel insight into the way T regulatory cells can be manipulated both to dampen immunity, which can be used to develop strategies to reduce immune mediated disease and limit transplant rejection. Read moreRead less
Evaluation of the potential of colostrum-derived anti-influenza antibody for the treatment and prevention of influenza. The project addresses a common disease problem, influenza, with a novel application of antibody technology. The technology may safely provide protection and cost effective treatment for those members of the community who are least protected by current approaches. The product can be cost-effective and readily available to enable the public to self medicate in high risk situation ....Evaluation of the potential of colostrum-derived anti-influenza antibody for the treatment and prevention of influenza. The project addresses a common disease problem, influenza, with a novel application of antibody technology. The technology may safely provide protection and cost effective treatment for those members of the community who are least protected by current approaches. The product can be cost-effective and readily available to enable the public to self medicate in high risk situations, or to be used as a public health tool in situtions to control outbreaks in those most susceptible to serious disease. The production system that enabled the creation of the technology is the advanced Australian dairy industry. Farmers with herds participating will receive a significant income benefit from, what was before, largely a waste product.Read moreRead less
Herpesvirus entry into mammalian hosts. Herpesviruses infect most mammals and cause much chronic disease. Our poor understanding of their host entry pathways limits infection control. The olfactory neuroepithelium has been identified as a key entry portal for both a murid herpesvirus and a human pathogen, Herpes simplex virus, suggesting that many herpesviruses use this route. Virions cross the olfactory mucus on neuronal cilia, then either infect neurons or transfer to glial cells for local spr ....Herpesvirus entry into mammalian hosts. Herpesviruses infect most mammals and cause much chronic disease. Our poor understanding of their host entry pathways limits infection control. The olfactory neuroepithelium has been identified as a key entry portal for both a murid herpesvirus and a human pathogen, Herpes simplex virus, suggesting that many herpesviruses use this route. Virions cross the olfactory mucus on neuronal cilia, then either infect neurons or transfer to glial cells for local spread. This project will identify key receptor interactions and map the extent of invasion. By advancing our basic understanding of these important viruses and their uptake at an abundantly exposed but little explored anatomical site, the project can establish a basis for vaccinating against chronic disease.Read moreRead less
Discovery Early Career Researcher Award - Grant ID: DE220101221
Funder
Australian Research Council
Funding Amount
$453,614.00
Summary
Revealing bat antibody recognition mechanism against bat-borne viruses. Bats act as asymptomic reservoir hosts for numerous zoonotic viruses that are lethal in humans, indicating that the bat immune system can control these viruses. However, little is known about bat immunity including how bat antibodies recognise bat-borne viruses. This project aims to study bat anti-viral antibodies by utilising innovative protein engineering, cutting-edge cryo-EM technology and single-cell isolation and seque ....Revealing bat antibody recognition mechanism against bat-borne viruses. Bats act as asymptomic reservoir hosts for numerous zoonotic viruses that are lethal in humans, indicating that the bat immune system can control these viruses. However, little is known about bat immunity including how bat antibodies recognise bat-borne viruses. This project aims to study bat anti-viral antibodies by utilising innovative protein engineering, cutting-edge cryo-EM technology and single-cell isolation and sequencing. The project seeks to uncover bat-borne zoonotic virus glycoprotein architecture and reveal how bat antibodies function to inhibit viral infection. Expected outcomes will be new insight and tools to combat emerging and yet to emerge pathogens, enabling pandemic preparedness and increasing global biosecurity.
Read moreRead less